Research Progress on the Relationship between the New Obesity Measurement Index and Fatty Liver Disease

肥胖已成为全球范围内严重的公共卫生问题，伴随而来的脂肪性肝病(FLD)也日益引起关注。传统的肥胖测量方法，如体重指数(BMI)和腰围，虽然广泛使用，但在评估个体脂肪分布及其代谢风险方面存在局限性。新型肥胖测量指数的提出，为肥胖的评估提供了更为全面的视角。这些新型指标能够更准确地反映体内脂肪的分布情况，从而帮助识别与脂肪性肝病相关的风险因素。研究表明，肥胖不仅增加了脂肪性肝病的发生风险，还可能加速其进展。深入探讨新型肥胖测量指数与脂肪性肝病之间的关系，对于改善临床诊断和干预策略具有重要意义。脂肪性肝病已成为全球范围内日益严重的健康问题，与肥胖密切相关。研究表明，肥胖不仅增加了脂肪性肝病的发生风险，还可能加速其进展。深入研究新型肥胖测量指数与脂肪性肝病之间的关系，能够帮助我们更好地理解肥胖对肝脏健康的影响机制。本研究通过对相关文献的系统回顾和分析，探讨了新型肥胖测量指数在评估脂肪性肝病风险中的有效性，并结合临床数据进行实证研究。新型肥胖测量指数在识别脂肪性肝病患者方面具有较高的敏感性和特异性，提示其在临床实践中具有重要的应用价值。本文的研究为肥胖与脂肪性肝病的关系提供了新的证据，强调了新型肥胖测量指数在临床评估中的重要性，为未来的研究和临床实践提供了参考。Obesity has become a critical global public health issue, with the accompanying fatty liver disease (FLD) attracting increasing attention. Traditional obesity measurement methods, such as body mass index (BMI) and waist circumference, while widely used, exhibit limitations in assessing individual fat distribution and metabolic risks. The proposal of the new obesity measurement index provides a more comprehensive perspective for obesity evaluation. These emerging metrics can more accurately reflect body fat distribution, thereby aiding in identifying risk factors associated with FLD. Studies indicate that obesity not only increases the risk of FLD onset but may also accelerate its progression. An in-depth exploration of the relationship between the new obesity measurement index and FLD is crucial for improving clinical diagnosis and intervention strategies. FLD has emerged as a growing global health concern closely linked to obesity. Research demonstrates that obesity exacerbates both the incidence and progression of FLD. Investigating the new obesity measurement index in relation to FLD enhances our understanding of obesity’s impact on liver health mechanisms. This study systematically reviewed and analyzed relevant literature to evaluate the effectiveness of the new obesity measurement index in assessing FLD risk, supplemented by empirical clinical data. The new obesity measurement index demonstrates high sensitivity and specificity in identifying FLD patients, highlighting their significant clinical utility. The findings provide new evidence for the obesity-FLD relationship, emphasize the importance of the new obesity measurement index in clinical evaluation, and offer valuable references for future research and practice.